Andrew Perry - Jan 3, 2022 Form 4 Insider Report for G1 Therapeutics, Inc. (GTHX)

Role: Chief Commercial Officer
Signature: /s/ James Stillman Hanson, attorney-in-fact
Stock symbol: GTHX
Transactions as of: Jan 3, 2022
Transactions value $: $0
Form type: 4
Date filed: 1/5/2022, 07:25 PM
Previous filing: Aug 17, 2021
Next filing: Jan 5, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	GTHX	Common Stock	Award	$0	+6K	+30000%	$0.00	6.02K	Jan 3, 2022	Direct	F1, F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	GTHX	Stock Options (Right to buy)	Award	$0	+26.5K		$0.00	26.5K	Jan 3, 2022	Common Stock	26.5K	$10.69	Direct	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents a restricted stock unit ("RSU") award that vests 25% on January 3, 2023 and 12.5% semi-annually thereafter, subject to the Reporting Person's continued service through each applicable vesting date.
F2	Each RSU represents a contingent right to receive one share of Issuer common stock.
F3	Represents (i) 20 shares of common stock; and (ii) 6,000 RSUs from award granted on January 3, 2022.
F4	The shares underlying this option vest as to 25% of the shares on January 3, 2023, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through each applicable vesting date.